Propanc Biopharma (PPCB) Balance Sheet: Assets & Liabilities

Propanc Biopharma (PPCB) Balance Sheet

As of Jun 30, 2026 (end of fiscal 2026), Propanc Biopharma reported total assets of $12.78M and total liabilities of $3.38M. Shareholders' equity was $9.40M, down 32.4% from $13.91M a year earlier. Total debt stood at $48.31K against $832.01K in cash and short-term investments, a net cash position of $783.70K. That puts debt-to-equity at 0.01, compared with 0.12 a year earlier.

Propanc Biopharma Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Propanc Biopharma, Inc. (PPCB) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Sep 2019	Jun 2018	Jun 2017
Current Assets
Cash and Cash Equivalents	0.83	0.01	0.02	0.01	0.00	0.00	0.07	0.00	0.02	0.07
Cash & Short-Term Investments	0.83	0.01	0.02	0.01	0.00	0.00	0.07	0.00	0.02	0.07
Accounts Receivable	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	7.70	8.34	0.00	0.01	0.01	0.00	0.00	0.08	0.03	0.00
Total Current Assets	8.54	8.35	0.03	0.02	0.02	0.01	0.07	0.09	0.06	0.08
Non-Current Assets
Property, Plant & Equipment (Net)	0.04	0.06	0.02	0.04	0.06	0.00	0.03	0.01	0.01	0.01
Other Non-Current Assets	4.19	11.22	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	4.24	11.28	0.05	0.04	0.07	0.01	0.03	0.01	0.01	0.01
Total Assets	12.78	19.63	0.07	0.06	0.08	0.01	0.10	0.10	0.07	0.10
Current Liabilities
Accounts Payable	1.13	1.25	1.21	1.00	0.94	1.00	0.84	0.92	1.16	0.00
Short-Term Debt	0.02	1.58	0.87	0.51	0.98	0.68	1.50	1.56	4.55	3.40
Accrued Liabilities	-	2.35	0.89	1.21	0.52	1.31	-	-	-	-
Other Current Liabilities	2.20	2.75	0.13	0.42	0.15	1.40	1.40	1.93	1.12	2.14
Total Current Liabilities	3.35	5.58	3.79	3.16	3.06	3.08	3.74	4.40	6.82	5.54
Non-Current Liabilities
Long-Term Debt	0.02	0.15	0.06	0.02	0.04	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.02	0.15	0.06	0.02	0.04	0.00	0.00	0.00	0.00	0.00
Total Liabilities	3.38	5.73	3.85	3.18	3.11	3.08	3.74	4.40	6.82	5.54
Stockholders' Equity
Common Stock	0.00	0.01	0.00	0.01	0.00	0.01	0.26	0.00	0.05	0.00
Retained Earnings	-144.48	-125.62	-66.70	-64.68	-61.56	-58.20	-55.78	-51.04	-45.28	-38.24
Accumulated Other Comprehensive Income	1.18	1.32	1.27	1.29	1.23	1.09	1.27	1.07	0.36	-0.14
Treasury Stock	-	0.05	0.05	0.05	0.05	-	-	-	-	-
Additional Paid-in Capital	152.71	138.20	61.70	60.31	57.36	54.03	50.61	45.67	38.12	32.93
Shares Outstanding	-	0.46	0.00	0.00	0.00	-	-	-	-	-
Total Stockholders' Equity	9.40	13.91	-3.78	-3.12	-3.02	-3.07	-3.64	-4.30	-6.75	-5.44
Total Liabilities & Equity	12.78	19.63	0.07	0.06	0.08	0.01	0.10	0.10	0.07	0.10

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Propanc Biopharma Balance Sheet

How much debt does Propanc Biopharma have?

Propanc Biopharma had total debt of $48.31K as of Jun 30, 2026, against $832.01K in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $1.73M a year earlier.

What are Propanc Biopharma's total assets?

Propanc Biopharma reported total assets of $12.78M as of Jun 30, 2026, down 34.9% from $19.63M a year earlier. Total liabilities were $3.38M.

What is Propanc Biopharma's shareholders' equity?

Propanc Biopharma's shareholders' equity was $9.40M as of Jun 30, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition